EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies

被引：0
作者：
Francisco Beca
Kevin Kensler
Benjamin Glass
Stuart J. Schnitt
Rulla M. Tamimi
Andrew H. Beck
机构：
[1] Beth Israel Deaconess Cancer Center,Cancer Research Institute
[2] Beth Israel Deaconess Medical Center,Department of Pathology
[3] Harvard Medical School,Department of Epidemiology
[4] Harvard T.H. Chan School of Public Health,undefined
[5] Channing Division of Network Medicine,undefined
[6] Department of Medicine,undefined
[7] Brigham and Women’s Hospital and Harvard Medical School,undefined
来源：
Breast Cancer Research | / 19卷
关键词：
Benign breast disease; Breast Cancer; Risk; EZH2; Nurses’ Health Studies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Estrogen alpha and progesterone receptor expression in the normal mammary epithelium in relation to breast cancer risk
    Lagiou, Pagona
    Georgila, Christina
    Samoli, Evangelia
    Lagiou, Areti
    Zourna, Pantelina
    Minaki, Ploumitsa
    Vassilarou, Dorothy
    Papadiamandis, Ioannis
    Stika, Constantinos
    Kalapothaki, Victoria
    Sekeris, Constantine E.
    Trichopoulos, Dimitrios
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (02) : 440 - 442
  • [32] Rotating Night-Shift Work and the Risk of Breast Cancer in the Nurses' Health Studies
    Wegrzyn, Lani R.
    Tamimi, Rulla M.
    Rosner, Bernard A.
    Brown, Susan B.
    Stevens, Richard G.
    Eliassen, A. Heather
    Laden, Francine
    Willett, Walter C.
    Hankinson, Susan E.
    Schernhammer, Eva S.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2017, 186 (05) : 532 - 540
  • [33] lncRNA HOTAIR Promotes DNA Repair and Radioresistance of Breast Cancer via EZH2
    Qian, Liyu
    Fei, Qiaoman
    Zhang, Haoran
    Qiu, Manman
    Zhang, Bo
    Wang, Qin
    Yu, Yang
    Guo, Chenxu
    Ren, Yu
    Mei, Mei
    Zhang, Ling
    Zhu, Yu
    Yang, Bing
    DNA AND CELL BIOLOGY, 2020, 39 (12) : 2166 - 2173
  • [34] EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
    Yoo, Kyung Hyun
    Hennighausen, Lothar
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2012, 8 (01): : 59 - 65
  • [35] EZH2 Exacerbates Breast Cancer by Methylating and Activating STAT3 Directly
    Zhao, Yi
    Hu, Zhansheng
    Li, Jincheng
    Hu, Tingyan
    JOURNAL OF CANCER, 2021, 12 (17): : 5220 - 5230
  • [36] Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies
    Johnatty, Sharon E.
    Spurdle, Amanda B.
    Beesley, Jonathan
    Chen, Xiaoqing
    Hopper, John L.
    Duffy, David L.
    Chenevix-Trench, Georgia
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) : 91 - 99
  • [37] Design, synthesis, and evaluation of VHL-based EZH2 degraders for breast cancer
    Xiao, Boren
    Shi, Zhichao
    Liu, Jiaqi
    Huang, Qiuhua
    Shu, Kaifei
    Liu, Funian
    Zhi, Cailian
    Zhang, Dandan
    Wu, Lihong
    Yang, Shiqi
    Zeng, Xiliang
    Fan, Tingting
    Liu, Zijian
    Jiang, Yuyang
    BIOORGANIC CHEMISTRY, 2024, 143
  • [38] SOX5 promotes breast cancer proliferation and invasion by transactivation of EZH2
    Sun, Chuntao
    Ban, Yunqing
    Wang, Kai
    Sun, Yanming
    Zhao, Zhihua
    ONCOLOGY LETTERS, 2019, 17 (03) : 2754 - 2762
  • [39] The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors
    Panousis, D.
    Patsouris, E.
    Lagoudianakis, E.
    Pappas, A.
    Kyriakidou, V.
    Voulgaris, Z.
    Xepapadakis, G.
    Manouras, A.
    Athanassiadou, A. M.
    Athanassiadou, P.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2011, 32 (02) : 156 - 159
  • [40] Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies
    Sharon E. Johnatty
    Amanda B. Spurdle
    Jonathan Beesley
    Xiaoqing Chen
    John L. Hopper
    David L. Duffy
    Georgia Chenevix-Trench
    Breast Cancer Research and Treatment, 2008, 109 : 91 - 99
12345